Hudson Bay Capital Management »

Bridgebio Pharma shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $8.6M 250k 34.57
2024-12-31 $3.1M 113k 27.44
2024-06-30 $987k 39k 25.33
2023-03-31 $1.2M 72k 16.58
2022-06-30 $908k 100k 9.08
2022-03-31 $508k 50k 10.16
2021-09-30 $937k 20k 46.85
2020-06-30 $326k 10k 32.60

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Netflix Call Option (NFLX)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Advanced Micro Devices Put Option (AMD)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Strategy Cl A New Call Option (MSTR)
Robinhood Mkts Com Cl A Call Option (HOOD)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Dollar Tree Call Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Bridgebio Pharma

Vanguard Group
Viking Global Investors
BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Farallon Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Jane Street
Susquehanna International
Invesco
Geode Capital Management
Frazier Life Sciences Management
Two Sigma Investments

View all funds holding Bridgebio Pharma